We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$43.4B
AUM Growth
+$3.14B
Cap. Flow
-$115M
Cap. Flow %
-0.27%
Top 10 Hldgs %
13.22%
Holding
2,192
New
164
Increased
795
Reduced
936
Closed
172

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$189M
2
WMB icon
Williams Companies
WMB
+$155M
3
AYX
Alteryx Inc
AYX
+$94.1M
4
ABBV icon
AbbVie
ABBV
+$87M
5
AMGN icon
Amgen
AMGN
+$78.1M

Sector Composition

Rank Sector Weight
1 Technology 17.44%
2 Healthcare 17.1%
3 Financials 12.78%
4 Industrials 10.38%
5 Consumer Discretionary 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CXT icon
1426
Crane NXT
CXT
$2.72B
$300K ﹤0.01%
4,851
+1,953
+67% +$114K
NXPI icon
1427
NXP Semiconductors
NXPI
$55.2B
$300K ﹤0.01%
1,211
-144
-11% -$33.3K
IART icon
1428
Integra LifeSciences
IART
$1.25B
$296K ﹤0.01%
8,341
-310
-4% -$12.4K
SGMT icon
1429
Sagimet Biosciences
SGMT
$650M
$293K ﹤0.01%
54,000
-43,276
-44% -$311K
VTRS icon
1430
Viatris
VTRS
$19.5B
$291K ﹤0.01%
24,369
-7,298
-23% -$87.9K
CODA icon
1431
Coda Octopus Group
CODA
$121M
$284K ﹤0.01%
49,221
-1,683
-3% -$9.8K
NXRT
1432
NexPoint Residential Trust
NXRT
$545M
$281K ﹤0.01%
8,735
+676
+8% +$21K
CTSH icon
1433
Cognizant
CTSH
$27.9B
$278K ﹤0.01%
3,789
-9,163
-71% -$700K
FOXF icon
1434
Fox Factory Holding Corp
FOXF
$812M
$276K ﹤0.01%
5,292
-1,893
-26% -$112K
RPRX icon
1435
Royalty Pharma
RPRX
$26B
$273K ﹤0.01%
9,000
-3,000
-25% -$88.4K
GHC icon
1436
Graham Holdings Company
GHC
$4.81B
$273K ﹤0.01%
355
-22
-6% -$15.7K
KYMR icon
1437
Kymera Therapeutics
KYMR
$9.67B
$272K ﹤0.01%
+6,766
New +$242K
WYNN icon
1438
Wynn Resorts
WYNN
$8.67B
$272K ﹤0.01%
2,656
+2,221
+511% +$220K
TXO icon
1439
TXO Partners LP
TXO
$844M
$269K ﹤0.01%
15,000
ADSK icon
1440
Autodesk
ADSK
$46B
$267K ﹤0.01%
1,027
-1,857
-64% -$470K
PFC
1441
DELISTED
Premier Financial Corp. Common Stock
PFC
$266K ﹤0.01%
13,115
-299
-2% -$6.23K
MPWR icon
1442
Monolithic Power Systems
MPWR
$56.4B
$261K ﹤0.01%
385
+114
+42% +$76.1K
PCH
1443
DELISTED
PotlatchDeltic
PCH
$261K ﹤0.01%
5,541
-4,382
-44% -$202K
CARR icon
1444
Carrier Global
CARR
$44.7B
$258K ﹤0.01%
4,437
-100
-2% -$5.62K
TFIN icon
1445
Triumph Financial Inc
TFIN
$1.52B
$257K ﹤0.01%
3,240
+295
+10% +$22.3K
WOLF icon
1446
Wolfspeed
WOLF
$1.25B
$255K ﹤0.01%
8,642
-18,272
-68% -$551K
FLWS icon
1447
1-800-Flowers.com
FLWS
$174M
$255K ﹤0.01%
23,533
+2,267
+11% +$23.3K
IFF icon
1448
International Flavors & Fragrances
IFF
$21.5B
$248K ﹤0.01%
2,886
+1,730
+150% +$139K
GME icon
1449
GameStop
GME
$11.1B
$248K ﹤0.01%
19,808
-3,278
-14% -$47.5K
CNQ icon
1450
Canadian Natural Resources
CNQ
$103B
$248K ﹤0.01%
6,490
+4,642
+251% +$155K

Similar funds

Federated Hermes's Q1 2024 Portfolio in Review

As of Q1 2024, Federated Hermes held 2,192 positions worth $43.4B, up 7.8% from $40.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Federated Hermes's Q1 2024 filing shows 164 new, 795 increased, 936 reduced and 172 closed positions. Its largest new stake was Kanzhun: 4,861,533 shares worth $85.2M. The largest sale was Medtronic, an estimated $189M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q1 2024 buy was Kanzhun: 4,861,533 shares worth $85.2M.
  • Federated Hermes added most to Bristol-Myers Squibb in Q1 2024, an estimated $193M increase.
  • Federated Hermes's biggest Q1 2024 reduction was Medtronic, cutting an estimated $189M.
  • Federated Hermes fully exited Alteryx Inc in Q1 2024, selling an estimated $94.1M.
  • Federated Hermes's ten largest holdings make up 13% of its $43.4B portfolio in Q1 2024.
  • Federated Hermes opened 164 new positions and closed 172 in Q1 2024.
  • Federated Hermes's portfolio value rose 7.8% quarter-over-quarter to $43.4B.

Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.